Calton & Associates’s DNP Select Income Fund DNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Buy
21,318
+3,045
+17% +$32.5K 0.03% 379
2026
Q1
$188K Sell
18,273
-2,913
-14% -$29.7K 0.03% 422
2025
Q4
$212K Buy
21,186
+67
+0.3% +$674 0.03% 415
2025
Q3
$211K Buy
21,119
+67
+0.3% +$660 0.03% 393
2025
Q2
$206K Buy
21,052
+67
+0.3% +$644 0.04% 361
2025
Q1
$208K Buy
+20,985
New +$198K 0.05% 314
2024
Q4
Sell
-32,630
Closed -$328K 214
2024
Q3
$328K Buy
+32,630
New +$298K 0.13% 159
2023
Q4
Sell
-29,756
Closed -$283K 250
2023
Q3
$283K Buy
29,756
+19,362
+186% +$195K 0.41% 66
2023
Q2
$109K Buy
+10,394
New +$109K 0.05% 204
2020
Q4
Sell
-13,532
Closed -$136K 391
2020
Q3
$136K Buy
+13,532
New +$144K 0.03% 326
2018
Q1
Sell
-2,503
Closed -$26K 560
2017
Q4
$26K Buy
+2,503
New +$28.2K 0.01% 835

Other funds holding DNP

Calton & Associates's DNP Position: Q2 2026 in Review

Calton & Associates increased its DNP Select Income Fund (DNP) stake by 17% in Q2 2026, buying an estimated $32.5K and bringing the position to 21,318 shares worth $230K. The position accounts for 0.03% of the portfolio, ranked #379.

Calton & Associates first reported a position in DNP in Q4 2017 and has held it in 11 quarters since. The position peaked at $328K in Q3 2024. 329 funds tracked by Wall St. Rank hold DNP as of Q2 2026.

  • Calton & Associates held 21,318 shares of DNP Select Income Fund worth $230K as of Q2 2026.
  • Calton & Associates bought 3,045 DNP Select Income Fund shares in Q2 2026, an estimated $32.5K.
  • DNP Select Income Fund made up 0.03% of Calton & Associates's portfolio in Q2 2026, its #379 holding.
  • Calton & Associates first reported a position in DNP Select Income Fund in Q4 2017 and has held it in 11 quarters since.
  • Calton & Associates's DNP Select Income Fund position peaked at $328K in Q3 2024.
  • 329 funds tracked by Wall St. Rank held DNP Select Income Fund as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.